Literature DB >> 16612068

Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-alpha IVS1-397 C/C genotype and established coronary artery disease.

Ayse Emre1, Sinan Sahin, Can Erzik, Zekeriya Nurkalem, Dilaver Oz, Beyazit Cirakoglu, Kemal Yesilcimen, Birsen Ersek.   

Abstract

UNLABELLED: Effect of hormone replacement (HRT) therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-alpha (ER-alpha) IVS1-397 C/C genotype and established coronary artery disease. BACKGROUND/AIMS: Associations between various ER-alpha polymorphisms and clinical phenotypes have been studied, including lipid levels and coronary atherosclerosis. We studied 48 postmenopausal women to determine the effect of ER-alpha IVS1-397 polymorphism on the response to treatment with HRT.
METHODS: The study had a randomized, double-blind, placebo-controlled and crossover design. Patients were divided into two groups according to ER-alpha IVS1-397 polymorphism: CC genotype (n = 9); CT or TT genotype (n = 39). HRT was given continuously for 4 weeks, with 4-week washout periods between the treatment periods. Brachial artery Doppler and Tl-201 scintigraphy were performed at the end of each treatment period.
RESULTS: HRT lowered total cholesterol, LDL-c and Apo-B levels from baseline values (all p < 0.05) and to a similar degree in CC and CT/TT genotype patients. HRT increased estradiol, HDL-c and Apo A-1 levels relative to baseline values, but to a greater degree in CC patients (p = 0.04, 0.05 and 0.04 by ANOVA, respectively). HRT increased peak forearm blood flow, brachial artery diameter during reactive hyperemia and endothelium-dependent dilation in both groups, but to a greater degree in CC patients (p = 0.03, 0.03 and 0.04 by ANOVA, respectively). Summed stress and rest scores were also more markedly reduced in CC patients (p = 0.04 and 0.05, respectively). The increase in estradiol levels was strongly correlated with the improvement in endothelium-dependent dilation (r = 0.66, p < 0.01), which in turn showed negative correlation with summed stress (r = -0.62, p < 0.01) and rest scores (r = -0.52, p < 0.05) in the CC genotype group.
CONCLUSION: These data suggest that the improvement in endothelium-dependent dilation and the reduction in perfusion abnormalities by increasing estradiol levels with HRT in postmenopausal women with coronary artery disease may differ with respect to different genotypes, the effect being more prominent in those patients with ER-alpha IVS1-397 CC genotype. Copyright 2006 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16612068     DOI: 10.1159/000092598

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  9 in total

1.  Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy.

Authors:  Cesar A Santa-Maria; Amanda Blackford; Anne T Nguyen; Todd C Skaar; Santosh Philips; Steffi Oesterreich; James M Rae; Zeruesenay Desta; Jason Robarge; Norah Lynn Henry; Anna M Storniolo; Daniel F Hayes; Roger S Blumenthal; Pamela Ouyang; Wendy S Post; David A Flockhart; Vered Stearns
Journal:  Clin Cancer Res       Date:  2015-10-13       Impact factor: 12.531

Review 2.  Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.

Authors:  Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-01

Review 3.  Vascular effects of estrogenic menopausal hormone therapy.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Rev Recent Clin Trials       Date:  2012-02

4.  Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.

Authors:  Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2013-10-04       Impact factor: 5.858

Review 5.  Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.

Authors:  Dia A Smiley; Raouf A Khalil
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

6.  ESR1 and PGR polymorphisms are associated with estrogen and progesterone receptor expression in breast tumors.

Authors:  Daniel L Hertz; N Lynn Henry; Kelley M Kidwell; Dafydd Thomas; Audrey Goddard; Faouzi Azzouz; Kelly Speth; Lang Li; Mousumi Banerjee; Jacklyn N Thibert; Celina G Kleer; Vered Stearns; Daniel F Hayes; Todd C Skaar; James M Rae
Journal:  Physiol Genomics       Date:  2016-08-19       Impact factor: 3.107

Review 7.  Sex/gender medicine. The biological basis for personalized care in cardiovascular medicine.

Authors:  Faisal A Arain; Fatima H Kuniyoshi; Ahmed D Abdalrhim; Virginia M Miller
Journal:  Circ J       Date:  2009-09-04       Impact factor: 2.993

8.  Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause.

Authors:  Virginia M Miller; Vesna D Garovic; Kejal Kantarci; Jill N Barnes; Muthuvel Jayachandran; Michelle M Mielke; Michael J Joyner; Lynne T Shuster; Walter A Rocca
Journal:  Biol Sex Differ       Date:  2013-03-28       Impact factor: 5.027

9.  Steroidal aromatase inhibitors have a more favorable effect on lipid profiles than nonsteroidal aromatase inhibitors in postmenopausal women with early breast cancer: a prospective cohort study.

Authors:  Xue Wang; Anjie Zhu; Jiayu Wang; Fei Ma; Jing Liu; Ying Fan; Yang Luo; Pin Zhang; Qing Li; Binghe Xu; Peng Yuan
Journal:  Ther Adv Med Oncol       Date:  2020-05-26       Impact factor: 8.168

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.